Brief: Encompass Health Q3 Adjusted EPS USD 1.03 Vs. IBES Estimate USD 0.94
28/10/2024 20:20
Oct 28 (Reuters) - Encompass Health Q3 adjusted EBITDA USD 269.3 million vs. IBES estimate USD 259.1 million. * Q3 adjusted free cash flow USD 189.7 million * Q3 operating revenue USD 1,351 million vs. IBES estimate USD 1,328 million
Recent news on Encompass Health
See all newsBrief: Encompass Health Issues Notice For Partial Redemption Of Its 4.500% Senior Notes Due 2028
Brief: Encompass Health Announces Pricing Of $500 Million Of Senior Notes Due 2034 In A Private Offering
Brief: Encompass Health Announces Private Offering Of Senior Notes
Brief: Encompass Health Announces Plans To Build A 50-Bed Inpatient Rehabilitation Hospital In Post Falls, Idaho
Brief: Encompass Health Declares Dividend On Common Stock